I’m really glad you’re asking this before moving forward, because at 27, the approach to “sagging” is often very different from what people expect. First, true sagging at your age is actually uncommon. What most patients describe as sagging is usually: Mild volume deficiency in the midface Subtle changes in contour that create shadows Or natural facial structure that gives a slightly lower or softer cheek appearance Where Sculptra fits in Sculptra (a biostimulatory injectable) works by gradually stimulating your own collagen production over time. It’s not an immediate filler—it builds volume slowly and diffusely. At 27, I tend to be very selective with Sculptra because: Your natural collagen production is still relatively strong You typically don’t need large-scale volume rebuilding Results are gradual and less predictable in smaller-volume concerns When it can make sense Sculptra may be appropriate if: There is true early volume loss You’re looking for a very subtle, gradual improvement You prefer a more natural, long-term collagen-building approach When I would reconsider If what you’re seeing is mild or more structural, I often find better results with: Small amounts of targeted hyaluronic acid filler in the midface Or even just refining contour rather than adding volume These options give more control and precision, especially in younger patients. My honest approach At 27, I don’t jump to Sculptra as a first-line treatment for cheeks unless there’s a very clear reason. Most of the time, a more conservative and targeted approach gives a cleaner, more natural result. The goal at your age isn’t to “rebuild,” it’s to refine and support what’s already there.